Skip to main content
. 2022 Aug 12;9:968272. doi: 10.3389/fmed.2022.968272

Table 3.

Patient-reported outcome measures selected for the studies included in the review.

Patient-reported outcome measure Number of times used n (%)
Euroqol-5 Dimension Index 70 (29.2%)
Other Generic measures 18 (7.5%)
European Organization for Research and Treatment of Cancer (EORTC) modules
EORTC QLQ-C30 with EORTC disease-specific module
EORTC QLQ-C30 without EORTC disease-specific module
99 (41.3%)
32 (32.3%)
30 (30.3%)
Functional Assessment of Chronic Illness Therapy (FACIT) measures
FACT-G with FACT disease-specific measure
FACT-G without FACT disease-specific measure
41 (17.1%)
3 (7.3%)
2 (4.9%)
Other disease-specific measures 12 (5%)
Total 240 (100%)